$ALMR Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.19 up 72.46% YoY
• Reported revenue of $33.55M up 68.51% YoY
• Alamar Biosciences raised full-year 2026 revenue guidance to $121M to $123M, representing growth of 64% at the midpoint versus full-year 2025, from previous expectations of $116M to $120M.